Acute and Subacute Encephalopathies: Deficiency States (Nutritional)

ABSTRACT

Optimal functioning of the central and peripheral nervous system is dependent on a constant supply of essential nutrients. Nutritional deficiencies of thiamine and niacin, rarely vitamin B₁₂, and possibly folate can cause a wide range of neuropsychiatric manifestations. Neurologic manifestations associated with these deficiency states are the focus of this review. The preventable and potentially treatable nature of these disorders makes this an important subject. Prognosis depends on prompt recognition and institution of appropriate therapy.

KEYWORDS

Thiamine - niacin - cobalamine - folate - deficiency

REFERENCES

• 1 Kumar N. Nutritional neuropathies.  Neurol Clin. 2007;  25 (1) 209-255
• 2 Sechi G, Serra A. Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management.  Lancet Neurol. 2007;  6 (5) 442-455
• 3 Kumar N. Neurologic presentations of nutritional deficiencies.  Neurol Clin. 2010;  28 (1) 107-170
• 4 Kumar N. Neurological aspects of cobalamin (B12) deficiency. In: Biller J, ed. Handbook of Clinical Neurology: Systemic Diseases. Amsterdam: Elsevier Science BV; 2011. In press
• 5 Reuler J B, Girard D E, Cooney T G. Current concepts. Wernicke's encephalopathy.  N Engl J Med. 1985;  312 (16) 1035-1039
• 6 Thomson A D, Cook C C, Touquet R, Henry J A. Royal College of Physicians, London . The Royal College of Physicians Report on Alcohol: guidelines for managing Wernicke's encephalopathy in the accident and emergency department.  Alcohol Alcohol. 2002;  37 (6) 513-521
• 7 Foster D, Falah M, Kadom N, Mandler R. Wernicke encephalopathy after bariatric surgery: losing more than just weight.  Neurology. 2005;  65 (12) 1987 discussion 1847
• 8 Singh S, Kumar A. Wernicke encephalopathy after obesity surgery: a systematic review.  Neurology. 2007;  68 (11) 807-811
• 9 Juhasz-Pocsine K, Rudnicki S A, Archer R L, Harik S I. Neurologic complications of gastric bypass surgery for morbid obesity.  Neurology. 2007;  68 (21) 1843-1850
• 10 Aasheim E T. Wernicke encephalopathy after bariatric surgery: a systematic review.  Ann Surg. 2008;  248 (5) 714-720
• 11 Doss A, Mahad D, Romanowski C A. Wernicke encephalopathy: unusual findings in nonalcoholic patients.  J Comput Assist Tomogr. 2003;  27 (2) 235-240
• 12 Zhong C, Jin L, Fei G. MR Imaging of nonalcoholic Wernicke encephalopathy: a follow-up study.  AJNR Am J Neuroradiol. 2005;  26 (9) 2301-2305
• 13 Fei G Q, Zhong C, Jin L et al.. Clinical characteristics and MR imaging features of nonalcoholic Wernicke encephalopathy.  AJNR Am J Neuroradiol. 2008;  29 (1) 164-169
• 14 Zuccoli G, Santa Cruz D, Bertolini M et al.. MR imaging findings in 56 patients with Wernicke encephalopathy: nonalcoholics may differ from alcoholics.  AJNR Am J Neuroradiol. 2009;  30 (1) 171-176
• 15 Koike H, Iijima M, Sugiura M et al.. Alcoholic neuropathy is clinicopathologically distinct from thiamine-deficiency neuropathy.  Ann Neurol. 2003;  54 (1) 19-29
• 16 Koike H, Ito S, Morozumi S et al.. Rapidly developing weakness mimicking Guillain-Barré syndrome in beriberi neuropathy: two case reports.  Nutrition. 2008;  24 (7-8) 776-780
• 17 Harper C G, Giles M, Finlay-Jones R. Clinical signs in the Wernicke-Korsakoff complex: a retrospective analysis of 131 cases diagnosed at necropsy.  J Neurol Neurosurg Psychiatry. 1986;  49 (4) 341-345
• 18 Choi K D, Oh S Y, Kim H J, Kim J S. The vestibulo-ocular reflexes during head impulse in Wernicke's encephalopathy.  J Neurol Neurosurg Psychiatry. 2007;  78 (10) 1161-1162
• 19 Harper C. Wernicke's encephalopathy: a more common disease than realised. A neuropathological study of 51 cases.  J Neurol Neurosurg Psychiatry. 1979;  42 (3) 226-231
• 20 Sechi G P, Bosincu L, Cossu R P et al.. Hyperthermia, choreic dyskinesias and increased motor tone in Wernicke's encephalopathy.  Eur J Neurol. 1996;  3 (Suppl 5) 133
• 21 Flint A C, Anziska Y, Rausch M E, Herzog T J, Williams O. A clinical and radiographic variant of Wernicke-Korsakoff syndrome in a nonalcoholic patient.  Neurology. 2006;  67 (11) 2015
• 22 Nasrallah K M, Mitsias P D. Orthostatic tremor due to thiamine deficiency.  Mov Disord. 2007;  22 (3) 440-441
• 23 Karaiskos I, Katsarolis I, Stefanis L. Severe dysphagia as the presenting symptom of Wernicke-Korsakoff syndrome in a non-alcoholic man.  Neurol Sci. 2008;  29 (1) 45-46
• 24 Flabeau O, Foubert-Samier A, Meissner W, Tison F. Hearing and seeing: Unusual early signs of Wernicke encephalopathy.  Neurology. 2008;  71 (9) 694
• 25 Kopelman M D, Thomson A D, Guerrini I, Marshall E J. The Korsakoff syndrome: clinical aspects, psychology and treatment.  Alcohol Alcohol. 2009;  44 (2) 148-154
• 26 Antunez E, Estruch R, Cardenal C, Nicolas J M, Fernandez-Sola J, Urbano-Marquez A. Usefulness of CT and MR imaging in the diagnosis of acute Wernicke's encephalopathy.  AJR Am J Roentgenol. 1998;  171 (4) 1131-1137
• 27 D'Aprile P, Tarantino A, Santoro N, Carella A. Wernicke's encephalopathy induced by total parenteral nutrition in patient with acute leukaemia: unusual involvement of caudate nuclei and cerebral cortex on MRI.  Neuroradiology. 2000;  42 (10) 781-783
• 28 Shin R K, Galetta S L, Imbesi S G. Wernicke encephalopathy.  Arch Neurol. 2000;  57 (3) 405
• 29 Bergui M, Bradac G B, Zhong J J, Barbero P A, Durelli L. Diffusion-weighted MR in reversible wernicke encephalopathy.  Neuroradiology. 2001;  43 (11) 969-972
• 30 Doherty M J, Watson N F, Uchino K, Hallam D K, Cramer S C. Diffusion abnormalities in patients with Wernicke encephalopathy.  Neurology. 2002;  58 (4) 655-657
• 31 Zuccoli G, Motti L. Atypical Wernicke's encephalopathy showing lesions in the cranial nerve nuclei and cerebellum.  J Neuroimaging. 2008;  18 (2) 194-197
• 32 Zuccoli G, Pipitone N. Neuroimaging findings in acute Wernicke's encephalopathy: review of the literature.  AJR Am J Roentgenol. 2009;  192 (2) 501-508
• 33 Zuccoli G, Siddiqui N, Bailey A, Bartoletti S C. Neuroimaging findings in pediatric Wernicke encephalopathy: a review.  Neuroradiology. 2010;  52 (6) 523-529
• 34 Shogry M E, Curnes J T. Mamillary body enhancement on MR as the only sign of acute Wernicke encephalopathy.  AJNR Am J Neuroradiol. 1994;  15 (1) 172-174
• 35 Shin N Y, Nam H S, Lee S K. Hemorrhagic Wernicke encephalopathy in a patient with liver transplantation.  Neurology. 2009;  73 (17) 1423
• 36 Thomson A D, Marshall E J. The treatment of patients at risk of developing Wernicke's encephalopathy in the community.  Alcohol Alcohol. 2006;  41 (2) 159-167
• 37 Serdaru M, Hausser-Hauw C, Laplane D et al.. The clinical spectrum of alcoholic pellagra encephalopathy. A retrospective analysis of 22 cases studied pathologically.  Brain. 1988;  111 (Pt 4) 829-842
• 38 Teare J P, Hyams G, Pollock S. Acute encephalopathy due to coexistent nicotinic acid and thiamine deficiency.  Br J Clin Pract. 1993;  47 (6) 343-344
• 39 Ishii N, Nishihara Y. Pellagra among chronic alcoholics: clinical and pathological study of 20 necropsy cases.  J Neurol Neurosurg Psychiatry. 1981;  44 (3) 209-215
• 40 Green R, Kinsella L J. Current concepts in the diagnosis of cobalamin deficiency.  Neurology. 1995;  45 (8) 1435-1440
• 41 Tefferi A, Pruthi R K. The biochemical basis of cobalamin deficiency.  Mayo Clin Proc. 1994;  69 (2) 181-186
• 42 Carmel R. Cobalamin, the stomach, and aging.  Am J Clin Nutr. 1997;  66 (4) 750-759
• 43 Carmel R. Current concepts in cobalamin deficiency.  Annu Rev Med. 2000;  51 357-375
• 44 Andrès E, Affenberger S, Vinzio S et al.. Food-cobalamin malabsorption in elderly patients: clinical manifestations and treatment.  Am J Med. 2005;  118 (10) 1154-1159
• 45 Carmel R, Green R, Rosenblatt D S, Watkins D. Update on cobalamin, folate, and homocysteine.  Hematology (Am Soc Hematol Educ Program). 2003;  62-81
• 46 Toh B H, van Driel I R, Gleeson P A. Pernicious anemia.  N Engl J Med. 1997;  337 (20) 1441-1448
• 47 Lindenbaum J, Healton E B, Savage D G et al.. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis.  N Engl J Med. 1988;  318 (26) 1720-1728
• 48 Healton E B, Savage D G, Brust J C, Garrett T J, Lindenbaum J. Neurologic aspects of cobalamin deficiency.  Medicine (Baltimore). 1991;  70 (4) 229-245
• 49 Carmel R, Melnyk S, James S J. Cobalamin deficiency with and without neurologic abnormalities: differences in homocysteine and methionine metabolism.  Blood. 2003;  101 (8) 3302-3308
• 50 Kumar N, Gross Jr J B, Ahlskog J E. Copper deficiency myelopathy produces a clinical picture like subacute combined degeneration.  Neurology. 2004;  63 (1) 33-39
• 51 Kosik K S, Mullins T F, Bradley W G, Tempelis L D, Cretella A J. Coma and axonal degeneration in vitamin B12 deficiency.  Arch Neurol. 1980;  37 (9) 590-592
• 52 Andres E, Kaltenbach G. Prevalence of vitamin B12 deficiency among demented patients and cognitive recovery with cobalamin replacement.  J Nutr Health Aging. 2003;  7 (5) 309-310 author reply 311
• 53 Saperstein D S, Wolfe G I, Gronseth G S et al.. Challenges in the identification of cobalamin-deficiency polyneuropathy.  Arch Neurol. 2003;  60 (9) 1296-1301
• 54 Solomon L R. Cobalamin-responsive disorders in the ambulatory care setting: unreliability of cobalamin, methylmalonic acid, and homocysteine testing.  Blood. 2005;  105 (3) 978-985
• 55 Carmel R. How I treat cobalamin (vitamin B12) deficiency.  Blood. 2008;  112 (6) 2214-2221
• 56 Savage D G, Lindenbaum J, Stabler S P, Allen R H. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies.  Am J Med. 1994;  96 (3) 239-246
• 57 Morita S, Miwa H, Kihira T, Kondo T. Cerebellar ataxia and leukoencephalopathy associated with cobalamin deficiency.  J Neurol Sci. 2003;  216 (1) 183-184
• 58 Andrès E, Fothergill H, Mecili M. Efficacy of oral cobalamin (vitamin B12) therapy.  Expert Opin Pharmacother. 2010;  11 (2) 249-256
• 59 Stabler S P. Screening the older population for cobalamin (vitamin B12) deficiency.  J Am Geriatr Soc. 1995;  43 (11) 1290-1297
• 60 Green R, Miller J W. Folate deficiency beyond megaloblastic anemia: hyperhomocysteinemia and other manifestations of dysfunctional folate status.  Semin Hematol. 1999;  36 (1) 47-64
• 61 Reynolds E H. Benefits and risks of folic acid to the nervous system.  J Neurol Neurosurg Psychiatry. 2002;  72 (5) 567-571
• 62 Reynolds E H. Benefits and risks of folic acid to the nervous system.  J Neurol Neurosurg Psychiatry. 2002;  72 (5) 567-571
• 63 Diaz-Arrastia R. Homocysteine and neurologic disease.  Arch Neurol. 2000;  57 (10) 1422-1427
• 64 Toole J F, Malinow M R, Chambless L E et al.. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.  JAMA. 2004;  291 (5) 565-575
• 65 Zittoun J. Congenital errors of folate metabolism.  Baillieres Clin Haematol. 1995;  8 (3) 603-616
• 66 Brouwer D A, Welten H T, Reijngoud D J, van Doormaal J J, Muskiet F A. Plasma folic acid cutoff value, derived from its relationship with homocyst(e)ine.  Clin Chem. 1998;  44 (7) 1545-1550
• 67 Lucock M, Yates Z. Measurement of red blood cell methylfolate.  Lancet. 2002;  360 (9338) 1021-1022
• 68 Stabler S P, Marcell P D, Podell E R, Allen R H, Savage D G, Lindenbaum J. Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectrometry.  J Clin Invest. 1988;  81 (2) 466-474